Appendix 4C - Q2 FY23 Quarterly Cash Flow Report
/PRNewswire/ -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease...
Source: prnewswire.com
Subcortical Structures News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Subcortical Structures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Subcortical Structures Today - Breaking & Trending Today
Appendix 4C - Q1 FY23 Quarterly Cash Flow Report
First patient dosed in Phase 2 clinical trial for ATH434 in New Zealand, trial opens in Europe and AustraliaApproval of Investigational New Drug a...
Source: businessinsider.com
Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting
/PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying...
Source: prnewswire.com